evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract
17930,GENE_BACKGROUND,,"The MDM2 gene encodes an E3 ubiquitin ligase that negatively regulates the p53 tumor suppressor protein (PMID: 8875929, 1535557, 25550083). The MDM2-p53 interaction blocks the activation domain of p53, inhibiting its transcriptional activity (PMID: 8875929, 25550083, 7686617). Additionally, the MDM2-p53 interaction results in increased proteasomal degradation of the p53 protein (PMID: 8653711, 9153396, 9153395, 9382809). Transcription of the MDM2 gene is directly activated by p53, and levels of both p53 and MDM2 are maintained at low levels in unstressed cells (PMID: 8265599, 8440237, 8319905). Cells may acquire oncogenic potential from p53 loss (50% of tumors) or MDM2 amplification, which cripple the p53 pathway in tumor cells (PMID: 10549356, 23161690, 9671804, 20025780). Recently, numerous studies targeting the interaction between p53 and MDM2 have resulted in the development of therapeutic strategies aimed at normalizing p53 levels in tumor cells (PMID: 14704432, 15715460, 16759082, 15956260, 17126603, 14704432, 15715460, 16759082, 15956260, 17126603).",,2017-07-31,,4193,MDM2,MDM2 proto-oncogene,True,ENST00000462284,NM_002392.5,hdm2,HDMX,ACTFS,False,8265599,The mdm-2 gene is induced in response to UV light in a p53-dependent manner.,Proceedings of the National Academy of Sciences of the United States of America,0001-12-15,90,24,11623-7,Perry ME et al,,,0001-12-15,,23161690,The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis.,Nucleic acids research,2018-01-01T20:13:00,41,Database issue,D962-9,Leroy B et al,doi: 10.1093/nar/gks1033,,0001-01-01,,8653711,In vivo ubiquitination and proteasome-mediated degradation of p53(1).,Cancer research,0001-06-01,56,11,2649-54,Maki CG et al,,,0001-06-01,,9382809,Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.,Current biology : CB,0001-11-01,7,11,860-9,BÃ¶ttger A et al,,,0001-11-01,,17126603,MDM2 inhibitors for cancer therapy.,Trends in molecular medicine,2018-01-01T20:07:00,13,True,23-31,Vassilev LT,,,0001-01-01,,8875929,Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.,"Science (New York, N.Y.)",0001-11-08,274,5289,948-53,Kussie PH et al,,,0001-11-08,,9671804,The MDM2 gene amplification database.,Nucleic acids research,0001-08-01,26,15,3453-9,Momand J et al,,,0001-08-01,,7686617,Mapping of the p53 and mdm-2 interaction domains.,Molecular and cellular biology,0001-07-01,13,7,4107-14,Chen J et al,,,0001-07-01,,8440237,mdm2 expression is induced by wild type p53 activity.,The EMBO journal,0001-02-01,12,2,461-8,Barak Y et al,,,0001-02-01,,8319905,The p53-mdm-2 autoregulatory feedback loop.,Genes &amp; development,0001-07-01,7,7A,1126-32,Wu X et al,,,2018-07-01T07:00:00,,10549356,p53 and human cancer: the first ten thousand mutations.,Advances in cancer research,2000,77,,81-137,Hainaut P et al,,,Hainaut P et al. Advances in cancer research. 2000;77()81-137.,,16759082,"Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction.",Journal of medicinal chemistry,2018-06-15T20:06:00,49,12,3432-5,Ding K et al,,,0001-06-15,,25550083,Structural and sequential context of p53: A review of experimental and theoretical evidence.,Progress in biophysics and molecular biology,2018-03-01T20:15:00,117,2001-02-03,250-63,Saha T et al,doi: 10.1016/j.pbiomolbio.2014.12.002,,2002-02-03,,14704432,In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.,"Science (New York, N.Y.)",2018-02-06T20:04:00,303,5659,844-8,Vassilev LT et al,,,0001-02-06,,15715460,Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.,Journal of medicinal chemistry,2018-02-24T20:05:00,48,4,909-12,Grasberger BL et al,,,0001-02-24,,20025780,"Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.",Journal of translational medicine,2017-12-22T20:09:00,7,,110,Zhang MF et al,doi: 10.1186/1479-5876-7-110,,0001-12-22,,15956260,p53 alpha-Helix mimetics antagonize p53/MDM2 interaction and activate p53.,Molecular cancer therapeutics,2018-06-01T20:05:00,4,6,1019-25,Chen L et al,,,0001-06-01,,9153396,Regulation of p53 stability by Mdm2.,Nature,0001-05-15,387,6630,299-303,Kubbutat MH et al,,,2018-05-15T03:03:00,,9153395,Mdm2 promotes the rapid degradation of p53.,Nature,0001-05-15,387,6630,296-9,Haupt Y et al,,,0001-05-15,,1535557,The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.,Cell,0001-06-26,69,7,1237-45,Momand J et al,,,0001-06-26,
17929,GENE_SUMMARY,,"MDM2, a ubiquitin ligase and p53 inhibitor, is amplified in a diverse range of cancers including well-differentiated liposarcomas.",,2017-01-20,,4193,MDM2,MDM2 proto-oncogene,True,ENST00000462284,NM_002392.5,hdm2,HDMX,ACTFS,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
